Abstract
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5+ B cells in lymphoid organs and peripheral blood. The incidence is high in people over 50 years of age and its prognosis is quite diverse, also affecting treatment. Several therapies are currently in use but, in some cases, there may be resistance and disease relapsing, which demands a search for new alternativ…